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that of cirrhosis group (P 0.001); additionally, there was
statistically signiﬁcant difference between CLF and ACLF
patients (P< 0.001). Plasma Af-Gc globulin signiﬁcantly
positive correlated with ALB, ALT, AST, CHE (P was 0.001,
0.001, 0.001, <0.001 respectively), while weak positive
correlated with TBIL, PLT. Meanwhile, there was signiﬁcantly
negative correlation between plasma Af-Gc globulin and
Child Pugh score (P= 0.02), while weak negative correlated
with INR. The level of Af-Gc globulin in liver failure
patients who were infected by ascites or hydrothorax were
markedly lower than that of non-infected (P= 0.015), the
levels of Af-Gc in encephalopathy presence were lower
than encephalopathy absent (P= 0.083). No statistically
signiﬁcant difference was noted in non-survivors and
survivors of liver failure patients.
Conclusions: Plasma Af-Gc globulin levels in liver failure
patients were signiﬁcantly reduced compared with cirrhosis
and healthy controls, but it can not be used to evaluate the
prognosis of liver failure patients.
Abbreviations: Alanine aminotransferase (ALT), aspartate
aminotransferase (AST), choline esterase (CHE), Albumin
(ALB), total bilirubin (TBIL), palsma international
normalized ratio of prothrombin time (INR), platelet (PLT)
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Objective: To evaluate the clinic effects of the modiﬁed
Sugiura procedure in treating gastroesophageal varices
bleeding.
Methods: Between April 2001 and December 2006,
117 patients with varices bleeding were treated with
the modiﬁed Sugiura procedure. Its clinic data were
retrospective analyzed. At the same time the clinic
data of 94 cases about the Hassab procedure between
July 1996 and March 2001 were taken as control group.
Operative complications, residual varices, recurrence of
varices bleeding and encephalopathy were observed.
Results: Two groups were not dead cases, encephalopathy
cases and recurrence cases of varices bleeding in the
duration of hospital stay. Sugiura group had 4 cases of
digestive tract leakage and 2 cases of esophageal stricture
relating with stapler transaction. Sugiura group and Hassab
group had 4 and 3 portal vein thrombosis cases respectively
(P> 0.05). At the ﬁrst year of post-operation, residual varices
rate was 21.3% in Sugiura group and 50% in Hassab group
(P< 0.05), and recurrent rate of varices bleeding was 0 in
Sugiura group and 10.3% in Hassab group (P< 0.05).
Conclusion: The modiﬁed Sugiura procedure has a good
effect in treating varices bleeding. It is better than
the Hassab procedure in diminishing residual varices and
preventing recurrence of varices bleeding.
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Introduction: According to recent concepts, pathologically
upregulated apoptosis in the liver both directly and
indirectly promotes inﬂammation and ﬁbrosis.
The aim of this study was to estimate apoptotic,
inﬂammatory and ﬁbrotic process in acute alcoholic
hepatitis with cholestasis.
Patients and Methods: 21 persons (alcohol surrogate users)
were admitted to Infectology Center of Latvia and diagnosed
with acute alcoholic hepatitis with intrahepatic cholestasis.
Diagnosis was conﬁrmed on the basis of clinical, biochemical
and morphological examination data. For comparison,
26 patients with acute alcoholic hepatitis without
cholestasis were included in this study. Serum level of
apoptosis marker cytokeratin 18 (CK-18) neoepitope (M30-
Apoptosense® ELISA kit, PEVIVA), ALT activity, C-reactive
protein and ﬁbrosis marker hyaluronic acid (ELISA, Corgenix
Inc., Colorado, USA) were detected.
Results: Obtained data show a high level of
CK-18 in patients with acute alcoholic hepatitis
with cholestasis (967.11± 111.20U/L) and without
cholestasis (1091.67± 153.30U/L; 40% <P< 50%). Serum
ALT activity in alcohol surrogate users was signiﬁcantly
higher (169.57± 47.54U/L) than in patients who used
qualitative ethanol (33.62± 3.27U/L; 99% <P< 99.9%).
Serum C-reactive protein level was signiﬁcantly higher
in patients without cholestasis (42.27± 6.79mg/L) than
in patients with cholestasis (27.13± 9.24mg/L; P> 99.9%).
Hyaluronic acid concentration was very high in sera of
patients with acute alcoholic hepatitis without cholestasis
(1006.46± 56.96 ng/ml) if compared with cholestatic acute
alcoholic hepatitis (271.67± 44.33 ng/ml; P> 99.9%).
Conclusion: Liver cell death in acute alcoholic hepatitis
is partially due to necrosis, but there is evidence that
apoptosis plays an important role in development of cell
injury. The extent of apoptosis process in clinical practice
usually is underestimated.
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Background and Aim: We use model for end-stage liver
disease (MELD) scoring system to predict 3-month prognosis
of patients with acute-on-chronic liver failure (ACLF) after
plasma exchange (PE) and lamivudine treatment and study
the predictive factors on the prognosis of patients.
Methods: 280 patients treated with lamivudine were
randomly divided into PE and control groups. The
relationship of mortality and inﬂuential factors of patients
were studied by univariate and multivariate analysis.
Results: The mortality (49.4%) of patients in PE group with
MELD score from 30 to 40 was lower than that (86.1%) of
control group (c2 = 24.546, P < 0.01). TBIL rebound rate of
dead group was signiﬁcantly higher than that of survival
group (P < 0.01). Univariate analysis showed that mortality
was signiﬁcantly related to age (P = 0.003), treatment
method (P = 0.000), TBIL (P = 0.010), MELD score (P = 0.001),
INR (P = 0.014), pretreatment HBVDNA load (P = 0.000),
decline of HBVDNA load during therapy (P = 0.013),
encephalopathy (P = 0.019) and hepatorenal syndrome
(P = 0.026). In multivariate analysis, in patients with MELD
scores 30 40, treatment method (P = 0.003), pretreatment
HBVDNA load (P = 0.009), decline of HBVDNA load during
therapy (P = 0.016) and encephalopathy (P = 0.015) were
independent predictors of mortality; for MELD scores
above 40, only MELD score (P = 0.012) was independent
predictive.
Conclusions: PE signiﬁcantly decreases the mortality of
patients with MELD score 30 40. For ACLF patients with
MELD score 30 40, a low viral load pre-treatment and quick
decline of HBVDNA load are good predictors for the survival
of PE and lamivudine treatment.
